Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with rheumatoid arthritis according to the standard 2010 classification guidelines used by doctors
- People who are older than 19 years of age
- People who are currently taking the medication methotrexate
- People who agree to receive the Shingrix vaccine (a shingles vaccine) as part of the trial
Who may not be able to join:
- People who have another type of inflammatory joint condition or an autoimmune disease other than rheumatoid arthritis
- People who currently have cancer, an active infection, or who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hong Ki Min, MD, PhD, Konkuk University Medical Center
Phone: +82-10-9977-5455
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cell-mediated immunity (CD4+ and CD8+ T cell against herpes zoster)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.